News From The Journal Of Clinical Investigation: May 2, 2011
HEMATOLOGY: TIF(f)1 between blood cell progenitors leads to leukemia Proteins whose normal function helps prevent the development of tumors are known as tumor suppressors. Tumors arise when expression of these proteins is reduced. A team of researchers, led by Laurent Delva and Jean-NoГ"l Bastie, at the University of Burgundy, France, has now identified the protein TIF1-gamma as a tumor suppressor in mouse and human chronic myelomonocytic leukemia (CMML). To analyze the function of TIF1-gamma in blood cells, Delva, Bastie, and colleagues generated mice lacking TIF1-gamma only in blood cells.
S.L.E. Lupus Foundation Announces New Grants To Further NYC Scientists' Leadership In Lupus Research
New York City's S.L.E. Lupus Foundation is pleased to name the latest recipients of its Career Development and Basic Science Fellowships: Josephine Isgro, MD of Hospital for Special Surgery (HSS), Dipyaman Ganguly, PhD of Columbia University Medical Center, and Yi Yan, PhD of the Feinstein Institute at North Shore-Long Island Jewish (LIJ) Hospital. These grants, totaling $420, 000, push the S.L.E. Lupus Foundation's lifetime investment in New York City-based lupus research past $17 million - an unparalleled sum for private sector lupus research funding and investigator training in any single metropolitan area.
Boston Scientific Announces Its Schedule For Heart Rhythm Society Scientific Sessions
Boston Scientific Corporation (NYSE: BSX) today announced its schedule of major events and sponsored research at the 32nd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 4 - 7 in San Francisco. The scheduled clinical presentations will provide new insights for physicians who treat patients with heart disorders including sudden cardiac arrest, atrial fibrillation and heart failure. Schedule of Events (All times are PT, with events to be held at the Moscone Center unless otherwise indicated.